Senescence-responsive miR-33-5p promotes chondrocyte senescence and osteoarthritis progression by targeting SIRT6

Area of Science:

• Biochemistry
• Molecular Biology
• Gerontology

Background:

• Osteoarthritis (OA) is a degenerative joint disease common in the elderly, characterized by cartilage breakdown.
• Chondrocyte senescence, an aging process in cartilage cells, plays a significant role in OA development.
• Antisenescence therapies are being explored as potential treatments for OA.

Purpose of the Study:

• To investigate the role of microRNA miR-33-5p in chondrocyte senescence and OA progression.
• To identify miR-33-5p as a potential therapeutic target for osteoarthritis.

Main Methods:

• Assessed miR-33-5p expression in senescent chondrocytes.
• Utilized miR-33-5p mimics and inhibitors to modulate chondrocyte senescence.
• Performed luciferase assays to confirm the targeting of SIRT6 mRNA by miR-33-5p.
• Analyzed correlations between SIRT6 expression, senescence, and OA severity in human cartilage.
• Induced OA-like changes in animal models via intraarticular injection of agomiR-33-5p.

Main Results:

• miR-33-5p expression was significantly upregulated in senescent chondrocytes.
• miR-33-5p mimics induced chondrocyte senescence, while inhibitors alleviated IL-1β-induced senescence.
• miR-33-5p directly targeted and downregulated SIRT6 expression.
• SIRT6 expression negatively correlated with chondrocyte senescence and OA severity in human samples.
• Intraarticular injection of agomiR-33-5p led to cartilage degradation and OA-like changes in vivo.

Conclusions:

• miR-33-5p acts as a pro-senescence factor that promotes osteoarthritis progression.
• SIRT6 is a direct target of miR-33-5p, mediating its effects on chondrocytes.
• miR-33-5p represents a promising therapeutic target for the treatment of osteoarthritis.